Assoc. Prof. Michael Hildebrand
Thursday 28th January, 2:00pm AEDT
Our fourth speaker is Associate Professor Michael Hildebrand with his talk “Somatic Mutation: The Hidden Genetics of Epilepsy”
Abstract
Epilepsy is a common disorder with a ~3-4% lifetime risk. In about 20-30% of cases there is a clear acquired cause (e.g., head trauma or stroke), but in the remaining group, genetic factors often play a role. The most common group, focal epilepsies (FEs), account for ~ 60% of all epilepsies. Some FEs, such as those caused by brain malformations, are amenable to resective surgery, allowing privileged access to brain tissue. Genetic analysis of epileptogenic brain malformations has revealed both inherited and de novo variants in genes of the mTOR and other pathways in a growing number of cases. Within these brain abnormalities (lesions) the pathogenic variants are present in only a fraction of the cells (mosaicism), yet this is sufficient to disrupt neuronal development and lead to FE.
The first step towards rational precision medicine treatments for FE, targeting the underlying neurobiological basis of seizures, is precision diagnosis for individual patients. The overall contribution of mosaic variants, and their associated developmental pathways, to FE is not known, and is limited by the current need for brain tissue to identify most mosaic FE-related variants. Novel, minimally invasive approaches are required to detect mosaic variants in patients with FE using alternate sources of DNA, particularly for patients with ‘non-lesional’ FE (i.e. without neuroimaging evidence of a lesion) and no brain tissue available for analysis.
Register for this webinar here